Oct 19, 2026 08:01AM

Oct 19, 2026 08:00AM

Oct 13, 2026 06:20AM

Oct 12, 2026 04:06PM

Oct 12, 2026 04:05PM

Oct 12, 2026 04:05PM

Oct 12, 2026 04:05PM TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's disease

Oct 9, 2026 07:01AM

Oct 9, 2026 07:00AM

Oct 7, 2026 09:59AM

Oct 2, 2026 06:03AM

Oct 2, 2026 06:00AM

Sep 29, 2026 08:05AM

Sep 29, 2026 08:03AM Johnson & Johnson presents new data reinforcing sustained disease control and improved daily function achieved with IMAAVY® (nipocalimab-aahu) in generalized myasthenia gravis (gMG)

Sep 25, 2026 11:32AM

Sep 25, 2026 07:30AM

Sep 25, 2026 07:00AM

Sep 23, 2026 09:47AM

Sep 23, 2026 09:46AM

Sep 21, 2026 08:00AM

Sep 21, 2026 08:00AM CAPLYTA® (lumateperone) shows significant and rapid improvement in bipolar mania in pivotal Phase 3 study

Sep 15, 2026 06:04AM

Sep 14, 2026 11:00PM

Sep 14, 2026 04:30AM

Sep 13, 2026 09:45PM

Sep 10, 2026 07:46AM

Sep 10, 2026 07:45AM

Sep 8, 2026 08:02AM Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026

Sep 8, 2026 08:00AM

Aug 26, 2026 02:00PM

Aug 24, 2026 07:13PM

Aug 24, 2026 07:12PM

Aug 5, 2026 10:26AM

Aug 5, 2026 10:25AM

Aug 4, 2026 09:05AM Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

Aug 3, 2026 02:37PM

Jul 30, 2026 08:30AM

Jul 30, 2026 08:30AM

Jul 23, 2026 08:31AM

Jul 23, 2026 08:30AM

Jul 22, 2026 07:01AM

Jul 22, 2026 07:00AM Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

Jul 15, 2026 06:20AM

Jul 8, 2026 07:45AM

Jul 8, 2026 07:45AM

Jun 30, 2026 09:00AM

Jun 26, 2026 12:35PM

Jun 26, 2026 12:35PM

Jun 14, 2026 02:01PM Johnson & Johnson shows positive results for TALVEY-DARZALEX drug combination

Jun 13, 2026 06:33AM

334,504 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All